特定の脂質異常は,遅発アルツハイマー病と固有の関連がある

Bruce M Cohen, Eunjung Koh, Kandice R Levental

medRxiv : the preprint server for health sciences

|August 20, 2025

まとめ

脳細胞のコレステロールエステルと脂肪酸の不均衡は,遅発アルツハイマー病 (LOAD) に先行する可能性があります. これらの脂質の変化は,早期のLOAD介入のための新しい経路を示唆しています.

科学分野:

神経科学
生物化学
遺伝学

背景:

遅発アルツハイマー病 (LOAD) の患者の脳,CSF,および血液に脂質異常が認められる.
これらの脂質の変化がLOADの原因か結果かは不明である.
誘発性多能幹細胞 (iPSC) 誘発性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC) 誘導性多能幹細胞 (iPSC)

研究の目的:

LOAD患者から得られた神経細胞の固有の脂質の違いを調査する.
LOADの前駆体として機能する特定の脂質異常を特定する.

主な方法:

LOAD患者と健康な対照群からのヒト iPSC 線は,アストロサイトに微分化されました.
全細胞とミトコンドリアの抽出物に対して,脂質分析を行った.

主要な成果:

コレステロールエステル (CE) と脂肪酸 (FA) の不均衡の有意な減少がLOADに関連した細胞とミトコンドリアで確認された.
膜脂質を含む他の脂質のクラスでは,わずかな変化が観察されました.

結論:

CEとFAの異常は,LOADの潜在的前駆体として特定されています.
これらの発見は,LOADの病原性における新しいメカニズムを強調しています.
早期の介入により,LOADの発症を予防または遅らせることが可能になる.

さらに関連する動画

06:02

Detection of Neuritic Plaques in Alzheimer's Disease Mouse Model

Published on: July 26, 2011

36.8K

07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

関連する概念動画

01:26

Alzheimer's Disease: Overview

666

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

666

01:22

Alzheimer's Disease: Treatment

260

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

260

03:03

Amyloid Fibrils

9.8K

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

9.8K

01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

290

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

290

01:30

Dementia

165

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....

165

01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

関連する実験動画